← All trials
NCT00131846
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2004
- Primary completion
- Aug 31, 2012
- Completion date
- Nov 30, 2013
- First posted
- Aug 19, 2005
- Last posted
- Mar 15, 2017
- Enrollment
- 1130
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kyoto UniversityLead sponsor
- Kyoto UniversityReponsible party - principal investigator
- University of the RyukyusCollaborator
- Kyoto UniversitySponsor investigator
- University of the RyukyusOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.